Interstitial Lung Disease Healthcare

Interstitial Lung Disease Treatment Market
May 2017
Report Id : REP-GB-3261
Status : Ongoing
Category : Healthcare, Pharmaceuticals & Medical Devices
©2015 Future Market Insights, All Rights Reserved
About
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities




Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage




Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
©2015 Future Market Insights, All Rights Reserved
2
Research Methodology (1/2)
Systematic Research Approach
1
Market profiling
2
Formulating discussion guide
3
Developing list of respondents
4
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
interviews
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
Data collection
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data validation
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
data
5
6
Data analysis
Insights
7
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
PMR delivers industry insights and
information in the required format
(PDF)
Data
Collection




Research &
Intelligence
Data Filter
& Analysis
Identifying key opinion leaders
Questionnaire design
In-depth interviews
Coverage across value chain
Actionable
Insights
A
Primary
Research






B
SOLUTION





Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
Primary Research #




Linkedin
Zoominfo
Salesforce
Avention
Business
Solution
Desk
Research
C
Key industry experts
Channel study
Developments
Market dynamics
Products
Conclusions
Company
Analysis
Secondary Research #




Company websites
Company annual
reports
White papers
Financial reports
Paid Publications#




Factiva
GBI
Genios
Meltwater
# includes sources of databases
©2015 Future Market Insights, All Rights Reserved
3
Interstitial Lung Disease Treatment Market
Interstitial lung disease (ILD) is a general category that includes many different lung conditions. All
interstitial lung diseases affect the interstitium, a part of the lung's anatomic structure. The interstitium is
a lace-like network of tissues that extends throughout both lungs. The interstitium provides support to
the lung’s microscopic air sacs (alveoli). Tiny blood vessels travel through the interstitium, allowing gas
exchange between blood and the air in the lungs. The disease affects the lungs in three ways. First, the
lung tissue is damaged. Second, the interstitium becomes inflamed. Finally, fibrosis (scarring) begins in
the alveoli (air sacs) and interstitium, and the lung becomes stiff, making it difficult to breathe. Interstitial
lung disease treatment includes a diverse collection of illnesses with a variety of causes, treatments, and
prognoses. Individuals who suffer from interstitial lung disease often have difficulty breathing and moving
from place to place due to a consistent feeling of shortness of breath. Disorders classified under
interstitial lung disease are often characterized by scarring of the lung's delicate tissues and a dry,
pestering cough. Interstitial lung disease is caused by environmental factors, removing these triggers can
slow the progression of the disease and damage to the lungs.
Interstitial Lung Disease Treatment Market: Dynamics
Registries of the epidemiology of different interstitial lung disease have been compiled in several
countries. However, they remain scarce due to the difficulties that arise in obtaining a specific diagnosis
as many of these conditions are rare. More than 250,000 people have been diagnosed with interstitial
lung disease in the United States, and nearly five million people have been diagnosed worldwide. It is
estimated that more than 41,000
©2015 Future Market Insights, All Rights Reserved
4
Interstitial Lung Disease Treatment Market
patients die each year from interstitial lung disease worldwide. The outlook for patients with interstitial
lung disease varies depending on the underlying cause of the disease. There is no absolute cure for
interstitial lung disease available as yet. A large portion of the treatment is directed to provide temporary
relieve to the patients. Failure to provide a complete cure and limited treatment options are considered
as major setbacks of the market. Limited drug options with low efficiency are further hindering the
growth of the global interstitial lung disease treatment market. UCSF has an active research program
conducting both clinical and basic research in the pathogenesis of lung fibrosis. Through the generosity of
patients, who collaborate with world-class physician scientists, they have developed a better
understanding of the fundamental, cellular and molecular mechanisms of interstitial lung disease. The
clinical research involves both observational studies and clinical trials that use the knowledge gained in
basic research to study the benefits of novel treatments in patients with lung fibrosis.\
Request For Report [email protected] http://www.futuremarketinsights.com/reports/sample/rep-gb-3261
Antibiotics may be given if a bacterial infection is responsible for the condition. Management of the
underlying disease process is also essential in a person with interstitial lung disease related to these
conditions. If the disease is thought to involve hypersensitivity, then the best therapy is avoidance of this
offending substance. Depending on the severity of the symptoms, respiratory support, including
supplemental oxygen and even ventilator support, may be required. Respiratory therapists may be part of
a treatment team with the goal of improving day to day function.
©2015 Future Market Insights, All Rights Reserved
5
Interstitial Lung Disease Treatment Market
Smoking cessation is an essential part of the treatment for anyone with interstitial lung disease.
Interstitial Lung Disease Treatment Market: Region-wise Outlook
Geographically, the market is segmented into North America, Eastern Europe, Western Europe, AsiaPacific excluding Japan, Japan Latin America, and the Middle East and Africa in which North America
holds a major share of the market for interstitial lung disease treatment
Visit For [email protected] http://www.futuremarketinsights.com/toc/rep-gb-3261
Interstitial Lung Disease Treatment Market: Key Players
Some of the hospitals and clinics providing treatment for interstitial lung disease treatment are
Cleveland, Barnes-Jewish Hospital, Brigham and Women's Hospital, Massachusetts General
Hospital, Johns Hopkins Hospital, Stanford Health Care, and UCSF Medical Center. Over the past
decade, the definition of interstitial lung disease and thus enrollment criteria for this disease have
become more specific. However, study design remains a challenge as there is continued debate on
what constitutes a clinically meaningful endpoint.
©2015 Future Market Insights, All Rights Reserved
6
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For media queries, contact the press office at
[email protected]
For other queries contact:
Harish Tiwari
(General Manager & Global Head Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
Thank You
Future Market Insights Global & Consulting Private Limited (FMI)
©2015 Future Market Insights, All Rights Reserved
7